Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Grant or award EVP, Research & CSO acquired 30,000 shares (grant or award)
  2. 4 Exercise or conversion Chief Medical Officer acquired 10,000 shares (option exercise)
  3. 4 Grant or award Chief Administrative Officer acquired 20,000 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 111,000 shares (grant or award)
  5. 4 Exercise or conversion Chief Medical Officer acquired 10,000 shares (option exercise)
  6. 5 Insider Annual Insider Trading Report
  7. 5 Insider Annual Insider Trading Report
  8. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $71.16 ($562,161)
  9. 4 Open-market sale Chief Business Officer sold 6,944 shares at $69.91 ($485,424)
  10. 4 Open-market sale EVP, Research & CSO sold 31,300 shares at $48.17 ($1,507,806)
  11. 4 Open-market sale EVP, Research & CSO sold 10,530 shares at $38.00 ($400,140)
  12. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $29.36 ($111,696)
  13. 4 Open-market sale Chief Business Officer sold 6,945 shares at $26.32 ($182,795)
  14. 4 Exercise or conversion EVP, Research & CSO acquired 9,500 shares (option exercise)
  15. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.19 ($118,683)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.27 ($118,966)
  19. 4 Open-market sale Chief Business Officer sold 6,945 shares at $31.53 ($218,968)
  20. 4 Exercise or conversion Chief Medical Officer acquired 7,500 shares (option exercise)

Page 19 of 25 · 491 filings